Aktien Sensor

QIAGEN NV plans to launch three new sample preparation instruments, QIAsymphony Connect, QIAmini, and QIAmini, by 2026 to improve lab automation and expand its market position.

QIAGEN NV’s stock price has seen moderate gains, but remains volatile ahead of its first-quarter 2025 financial results, which are scheduled to be released on May 7.

Qiagen’s stock price has plummeted amid concerns of a global trade war and a patent dispute with bioMérieux, but the company’s intellectual property protection efforts may pay off in the lucrative in situ hybridization market.